Introduction: This study aimed to determine the association of AGT1R and AGT2R polymorphisms with preeclampsia and whether these are affected by environmental factors and fetal sex. Methods: Overall 3234 healthy nulliparous women, their partners and babies were recruited prospectively to the SCOPE study in Adelaide and Auckland. Data analyses were confined to 2121 Caucasian parent-infant trios, among whom 123 had preeclamptic pregnancies. 1185 uncomplicated pregnancies served as controls. DNA was extracted from buffy coats and genotyped by utilizing the Sequenom MassARRAY system. Doppler sonography on the uterine arteries was performed at 20 weeks' gestation. Results: Four polymorphisms in AGT1R and AGT2R genes, including AGT1R A1166C, AGT2R C4599A, AGT2R A1675G and AGT2R T1134C, were selected and significant associations were predominately observed for AGT2R C4599A. When the cohort was stratified by maternal BMI, in women with BMI ! 25 kg/m 2 , the AGT2R C4599A AA genotype in mothers and neonates was associated with an increased risk for preeclampsia compared with the CC genotype [adjusted OR 2.1 (95% CI 1.0e4.2) and adjusted OR 3.0 (95% CI 1.4e6.4), respectively]. In the same subset of women, paternal AGT2R C4599A A allele was associated with an increased risk for preeclampsia and uterine artery bilateral notching at 20 weeks' gestation compared with the C allele [adjusted OR 1.9 (95% CI 1.1e3.3) and adjusted OR 2.1 (95% CI 1.3e3.4), respectively]. Conclusion: AGT2R C4599A in mothers, fathers and babies was associated with preeclampsia and this association was only apparent in pregnancies in which the women had a BMI ! 25 kg/m 2 , suggesting a geneeenvironment interaction.
Introduction
Preeclampsia affects up to 7% of nulliparous pregnancies and is a major cause of maternal and perinatal morbidity and mortality worldwide [1, 2] . To date, the exact cause of preeclampsia is still unknown. Since hypertension is both a risk factor and a symptom of preeclampsia, the renin angiotensin system (RAS), which plays an important role in blood pressure regulation, electrolyte and volume homeostasis [3] , has been studied intensively for its contribution to the development of the disorder.
In third trimester preeclamptic women are reported to have reduced plasma renin activity [4] , increased serum angiotensin converting enzyme (ACE) activity [4] , reduced angiotensin II (ANG II) concentration [4] and increased responsiveness to ANG II [5, 6] compared to women with normal pregnancy. The aberrant RAS levels/activities observed in preeclamptic pregnancies may indicate the involvement of RAS in the pathogenesis of preeclampsia. Therefore, genetic polymorphisms in the RAS components, which modulate RAS levels/activities, may potentially predispose women to preeclampsia.
Over the past decade, several polymorphisms in the AGT1R and AGT2R genes have been identified. AGT1R A1166C (rs5186) is located in the 3 0 UTR of AGT1R on the chromosome 3. The AGT1RA1166C CC genotype is associated with greater ANG II responsiveness [7] and increases risk for coronary artery disease and myocardial infarction [8] compared with the AA genotype. AGT2R C4599A (rs11091046), AGT2R A1675G (rs1403543) and AGT2R T1134C (rs12710567) are located in the 3 0 UTR of exon 3, intron 1 and the promoter region of the AGT2R gene on the X chromosome, respectively. The AGT2R A1675G G allele is associated with higher AGT2R expression compared with the A allele [9] . The functional effects of AGT2R C4599A and AGT2R T1334C on AGT2R have not been investigated previously. AGT2R A1675G and AGT2R C4599A have been shown to be in linkage disequilibrium in a Japanese population [10] . In a Chinese cohort, the AGT2R T1334C C allele is associated with an increased risk for essential hypertension compared with the T allele [11] .
In the current study, our primary aim was to determine if the aforementioned AGT1R and AGT2R polymorphisms in mothers, fathers and babies were associated with preeclampsia. Since assessing geneeenvironment interactions is becoming an increasingly important aspect of genetic association studies [12, 13] , our secondary aim was to determine whether the association of AGT1R and AGT2R polymorphisms with preeclampsia is affected by risk factors for preeclampsia, including maternal age [14, 15] , BMI [16] , green leafy vegetable intake [17] , fruit intake [18] , socio-economic status [19] and smoking [20] . In addition, since RAS components are sexually dimorphic in adults [21] , we explored our primary and secondary aims in pregnancies bearing female and male infants separately.
Materials and methods

Ethics approval
In Australia, ethical approval was obtained from the Central Northern Adelaide Health Service Ethics of Human Research Committee (study number: REC 1714/5/ 2008). In New Zealand, ethical approval was given by the Northern Region Ethics Committee (study number: AKX/02/00/364). All participants provided written informed consent. Australian clinical trial registry number: ACTRN 12607000551493.
Participants
The current study is a nested case control study embedded in a large prospective multicentre study, Screening for Pregnancy Endpoints (SCOPE). The participants were healthy nulliparous women with singleton pregnancies recruited to the SCOPE study between November 2004 and September 2008 in Adelaide, Australia and Auckland, New Zealand [22] . SCOPE is a prospective study with the main aim of developing screening tests to predict preeclampsia, small for gestational age infants and spontaneous preterm birth. Overall 3196 women, their partners and babies were recruited into the study. The population for this genetic study was confined to the 2121 Caucasian parent-infant trios (66%) (Fig. 1 ).
Women were recruited to the SCOPE study through hospital antenatal clinics, obstetricians, general practitioners, community midwives and self referral in response to advertisements or recommendations of friends. Women were excluded if they were judged to be at high risk of preeclampsia, small for gestational age babies or spontaneous preterm birth because of underlying medical conditions, gynaecological history, three or more previous miscarriages or three or more terminations of pregnancy or if they had received interventions that might modify pregnancy outcome [22] .
Participants were interviewed and examined by a research midwife at 15 AE 1 weeks of gestation. Maternal demographic and dietary information was collected, including ethnicity, age, height, weight, birthweight, gestational age at birth, socio-economic index (SEI 1 ) [23] , smoking status at 15 weeks' gestation and pre-pregnancy green leafy vegetable intake. Two consecutive manual blood pressure measurements were recorded. Paternal information, including age, birth weight, height and weight, were also recorded. Newborn measurements were recorded by research midwives usually within 72 h of birth. The recorded parameters included infant's gestational age at birth, body length, head circumference, mid arm circumference, birth weight and customised birthweight centile. Ultrasound and Doppler studies of the umbilical and uterine arteries were performed at 20 weeks' gestation [24] . Bilateral notching is defined as the presence of early diastolic notching in the waveform of both uterine arteries [25] .
Sample collection
Whole blood was collected in EDTA tubes from women at 15 AE 1 weeks of gestation, from partners at some time during the woman's pregnancy and umbilical cord after delivery. Blood samples were centrifuged and plasma and buffy coat separated and stored within 3 h of collection. Buccal swabs or saliva samples were collected from partners who were unwilling to undergo venepuncture and babies whose cord blood was not obtained at delivery. The buccal swabs were applied to Whatman FTA cards (Whatman, USA) immediately following sample collection and saliva was collected using Oragene kits (DNA genotek, USA).
Pregnancy outcome definitions
Preeclampsia was defined as systolic blood pressure !140 mm Hg or diastolic blood pressure !90 mm Hg, or both, on at least two occasions 4 h apart after 20 weeks' gestation but before the onset of labour or postpartum, with either proteinuria (24 h urinary protein !300 mg or spot urine protein: creatinine ratio !30 mg/mmol creatinine or urine dipstick protein !þþ) or any multisystem complication of preeclampsia [18] .
Uncomplicated pregnancies were normotensive pregnancies with delivery of a healthy and appropriately grown infant at !37 weeks' gestation.
Genotyping assays
DNA was extracted from buffy coats isolated from peripheral or cord blood (QiAamp 96 DNA blood kit), Whatman FTA cards or from saliva (Oragene Ò DNA kits) following the manufacturers' instructions. Genotyping was performed by the Australian Genome Research Facility (AGRF) utilizing the Sequenom MassARRAY system. Two quality control procedures were in place to ensure the accuracy of genotyping data: 1) Each sample was genotyped for Amelogenin to assess the consistency between the sex of samples and the corresponding Amelogenin genotype [26] . 2) Parental and neonatal genotyping data were checked for a Mendelian pattern of inheritance. The samples with inconsistent results in either step were excluded from the analyses. In addition, some samples were excluded due to inadequate blood samples, low quality of DNA or failure to genotype. The sample sizes for the genotyping data are shown in the results tables.
Statistics
Chi-square test was used to test the genotypes at each polymorphic locus for HardyeWeinberg Equilibrium (HWE). Independent samples t test (for continuous variables) and chi-square (for categorical variables) were used to compare characteristics between uncomplicated pregnancies and preeclampsia. The association of polymorphisms with preeclampsia and uterine artery bilateral notching was assessed by using logistic regression and odds ratios (OR) were generated. All data analyses were performed using PASW (SPSS, Chicago) version 17.02. P < 0.05 was considered statistically significant.
Results
Study population
Of the 3234 recruited women, 1113 (34%) women were excluded due to one of the reasons shown in Fig. 1 . The final analyses were conducted on 2121 Caucasian women, consisting of 1185 (55.9%) women with uncomplicated pregnancies, 123 (5.8%) preeclamptic women and 813 (38.3%) women with other complications.
For the 2121 Caucasian parent-infant trios, genotype data of up to 199 (9.4%) women, 470 (22.2%) partners and 578 (27.3%) infants could not be analysed for one of the following reasons: non availability of samples, genotyping failure or Mendelian inconsistencies in parent-infant genotypes. The available genotype data of each polymorphism for uncomplicated and preeclamptic pregnancies are shown in Table 2 .
Characteristics of the population
Women who later developed preeclampsia were on average younger, heavier, had higher sBP and dBP at 15 weeks' gestation, were less likely to consume !1 serve/day of fruit and green vegetables prior to pregnancy and they themselves weighed less at birth than the women with uncomplicated pregnancies (Table 1) . Partners who fathered a preeclamptic pregnancy on average were younger and heavier than those with uncomplicated pregnancies. Infants born to preeclamptic pregnancies were smaller (adjusted for gestational age where appropriate) in all neonatal measures than those born to uncomplicated pregnancies (Table 1 ). In addition, there was no difference in sex ratio between preeclampsia and uncomplicated pregnancy groups (Table 1) .
The association of polymorphisms with preeclampsia and bilateral notching at 20 weeks' gestation
The analyses for the association of polymorphisms with preeclampsia were performed comparing the uncomplicated and preeclampsia groups (Fig. 1) . The association of polymorphisms with uterine artery bilateral notching at 20 weeks' gestation were analysed in uncomplicated, preeclampsia and other complications group (Fig. 1) . For subgroup analyses, the cohort was stratified by environmental factors, including maternal age (age <29 years versus !29 years), maternal BMI (BMI < 25 kg/m 2 versus !25 kg/m 2 ), SEI (SEI < 34 versus !34), pre-pregnancy green leafy vegetable intake (vegetable intake <1 serve/day versus !1 serve/day), pre-pregnancy fruit intake (fruit intake <1 serve/day versus !1 serve/day) and smoking status at 15 weeks' gestation (no smoking versus smoking).
Since AGT2R is on the X chromosome, male partners only have one allele of the AGT2R polymorphisms. Accordingly, analyses on partners were performed in the fashion of alleles. Male neonates also have one allele of the AGT2R polymorphisms, however, since sample size of male neonates was small, we grouped it with female neonates and data were analysed in the fashion of genotypes. Take the AGT2R C4599A polymorphism as an example, male neonates with C allele were allocated to the CC genotype group and those with A allele were allocated to the AA genotype group.
AGT1R A1166C and AGT2R T1334C
Since the frequency of maternal and neonatal AGT2R T1334C CC genotype was less than 3%, the CC and CT genotype were combined. AGT1R A1166C and AGT2R T1334C were not associated with preeclampsia nor with uterine artery bilateral notching at 20 weeks' gestation (Table 2 ).
3.3.2. AGT2R C4599A AGT2R C4599A in mothers, partners and neonates was not associated with preeclampsia nor with uterine artery bilateral notching at 20 weeks' gestation (Table 2) . However, when the cohort was stratified by maternal BMI using 25 kg/m 2 as the cut-off point, among women with BMI ! 25 kg/m 2 , maternal AGT2R
C4599A AA genotype and paternal AGT2R C4599A A allele were associated with an increased risk for preeclampsia with OR 2.1 (95% CI 1.0e4.2) and OR 1.9 (95% CI 1.1e3.2), respectively (Table 3 ). In neonates, AGT2R C4599A CA and AA genotype both increased the risk for preeclampsia in women with BMI !25 kg/m 2 with OR 3.5 (95% CI 1.6e7.9) and OR 3.0 (95% CI 1.4e6.5), respectively (Table 3 ). In addition, the paternal AGT2R C4599A A allele was also associated with an increased risk for uterine artery bilateral notching at 20 weeks' gestation [OR 2.1 (95% CI 1.3e3.4)] (Table 3 ). All these associations remained after adjusting for the potential confounding factor, maternal SEI, which is closely related to BMI where women with low SEI are more likely to have a higher BMI than women with high SEI (Table 3) .
AGT2R A1675G
AGT2R A1675G was not associated with preeclampsia nor with uterine artery bilateral notching at 20 weeks' gestation (Table 2) . When the cohort was stratified by maternal BMI, among women with BMI ! 25 kg/m 2 , neonatal AGT2R A1675G AG genotype was associated with an increased risk for preeclampsia with OR 2.5 (95% CI 1.2e5.4). There was a trend for maternal GG genotype, paternal G allele and neonatal GG genotype of AGT2R A1675G to associate with an increased risk for preeclampsia (Table 4 ). In fact, after adjusting for maternal SEI, the paternal G allele was associated with an increased risk for preeclampsia with OR 1.9 (95% CI 1.0e3.1) ( Table 4 ). In addition, among women with BMI ! 25 kg/m 2 , paternal AGT2R A1675G G allele increased the risk for uterine artery bilateral notching [OR 1.6 (95% CI 1.0e2.7] (Table 4) . Moreover, neonatal AGT2R A1675G GG genotype also tended to associate with an increased risk for uterine artery bilateral notching among women with BMI ! 25 kg/m 2 ( Table 4 ).
Discussion
In the current study, in women with BMI ! 25 kg/m 2 , maternal, paternal and neonatal AGT2R C4599A was associated with preeclampsia. In the same subset of women, a similar non-significant trend was also observed for maternal, paternal and neonatal AGT2R A1675G, which has previously been shown to be in linkage disequilibrium with AGT2R C4599A [10] . Furthermore, in women with BMI ! 25 kg/m 2 , paternal AGT2R C4599A A allele and paternal AGT2R A1675G G allele were associated with an increased risk for uterine artery bilateral notching at 20 weeks' gestation. The observed association of maternal AGT2R C4599A with preeclampsia is consistent with a recent Romanian study [27] , in which women bearing the AGT2R C4599A AA genotype were at an increased risk of developing preeclampsia with OR 3.8 (95% CI 1.1e12.5). The novelties of the current study include 1) paternal and neonatal association of this polymorphism with preeclampsia and 2) modulation of these associations by maternal BMI.
Epidemiological studies have shown that the risk of preeclampsia is determined not only by maternal predisposition, but also by a paternal contribution. Men born to a preeclamptic pregnancy are twice as likely to father a preeclamptic pregnancy [28] . In addition, men who have fathered a preeclamptic pregnancy are nearly twice as likely to father a preeclamptic pregnancy with a different woman, regardless of whether she has already had a preeclamptic pregnancy or not [29] . The paternal and neonatal association of AGT2R C4599A with preeclampsia observed in the current study provides further evidence for the paternal genetic contribution to preeclampsia.
The mechanism behind the association of AGT2R C4599A with preeclampsia is yet to be determined. However, since the association was found in fathers and neonates and since the polymorphism in fathers was also associated with uterine artery bilateral notching, an indication of high uterine artery resistance and inadequate trophoblast invasion [25] , the placenta is likely to be involved. The expression of AGT2R in the placenta has been documented across gestation [30, 31] , however, its role in placentation is poorly understood. Since AGT2R has been shown to induce apoptosis in various cells types [32e34] and preeclampsia is characterised by an increased rate of trophoblast apoptosis [35, 36] , it is tempting to speculate that trophoblast apoptosis may hold the key to the association of AGT2R C4599A with preeclampsia. Furthermore, since AGT2R A1675G, known to be in linkage disequilibrium with AGT2R C4599A [10] , associates with AGT2R expression in vitro [9] , one would expect such an association for AGT2R C4599A, that is, the A allele of AGT2R C4599A is associated with higher AGT2R expression. Taken all together, the A allele or AA genotype of AGT2R C4599A in parent-infant trios, which may associate with higher AGT2R expression in the placenta, potentially links to an increased rate of trophoblast apoptosis and consequently leads to an increased risk for preeclampsia.
Gene-environment interaction describes the phenomenon in which association of a genetic variant with a disease phenotype varies with the degree of exposure to an environmental factor or vice versa. In the current study, the associations of AGT2R polymorphisms with preeclampsia and uterine artery bilateral notching at 20 weeks' gestation were only observed among women with BMI ! 25 kg/m 2 but not among those with BMI < 25 kg/m 2 , suggesting an interaction between AGT2R polymorphisms and maternal BMI. Elevated BMI is a well established risk factor for preeclampsia [37] . In our SCOPE cohort, for every 5 units increment in maternal BMI, there is a 1.3-fold increase in risk for preeclampsia [18] . The AGT2R-BMI interaction observed in the current study may suggest that the adverse effects associated with AGT2R C4599A A allele or AA genotype are subtle and can only place women at risk for preeclampsia or uterine artery bilateral notching if superimposed on adverse effects associated with elevated BMI such as chronic inflammation [38] . The strength of this study is its large multicentre prospective design. In addition, the outcome data of these cases were reviewed by highly skilled SCOPE clinicians to ensure accurate diagnosis. The weakness of the study is the missing genotypes of some participants, which reduced our sample size and may potentially introduce bias into our results. However, there are no systematic reasons for missing genotypes identified. Furthermore, although we performed multiple comparisons, which would increase the likelihood of obtaining false positive results, our significant data were supported by the consistencies between mother, father and baby, between AGT2R polymorphisms in linkage disequilibrium and between preeclampsia and uterine artery bilateral notching, which makes it unlikely that our findings are due to chance.
In summary, we have shown that AGT2R C4599A in mothers, fathers and neonates is associated with preeclampsia. The association was further strengthened by its association with uterine artery bilateral notching at 20 weeks' gestation, an indication of poor placental blood flow. More interestingly, these associations were modulated by maternal BMI and only observed in women with BMI ! 25 kg/m 2 , indicating an AGT2R polymorphism-BMI interaction. Finally, our data and those of others [12] , demonstrate that genetic polymorphisms often have low penetrance and for complex disorders we recommend including clinical and lifestyle factors together with polymorphisms in the analyses to elucidate their associations more clearly [39] .
Conflict of interest
None of the authors have any conflicts of interest to declare.
Funding
The Australian SCOPE study was funded by the Premier's Science and Research Fund, Government of South Australia. The New Zealand SCOPE study was funded by New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council; Evelyn Bond Fund, Auckland District Health Board Charitable Trust. Genotyping and data analyses were funded by the National Health and Medical Research Council Australia (NHMRC) Project Grant 565320 awarded to CTR and GAD and by the University of Adelaide. CTR is supported by an NHMRC Senior Research Fellowship APP1020749. None of the study sponsors had a role in study design, data analysis and interpretation or in writing this report.
